Bristol Myers' lung disease drug succeeds at lower dose in late-stage trial - Reuters

Reuters

Bristol Myers' lung disease drug succeeds at lower dose in late-stage trial Reuters

Bristol Myers' lung disease drug succeeds at lower dose in late-stage trial Reuters

Ver fuente original → ← Volver a noticias